Forskning
Udskriv Udskriv
Switch language
Region Hovedstaden - en del af Københavns Universitetshospital

Avertas - Changes in weight, body composition and metabolic parameters after switch to dolutegravir/lamuvidine compared to continued treatment with dolutegravir/abacavir/lamuvidine for virologically suppressed HIV infection: A randomized open-label superiority trial. AVERTAS-1 trial and AVETAS-2 trial

Projekt: Typer af projekterProjekt

Vis graf over relationer
StatusIgangværende
Periode01/09/2020 → …

ID: 67596838